ELANCO AH 0343 OESTRADIOL COMPUDOSE 400 Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco ah 0343 oestradiol compudose 400

elanco australasia pty ltd - oestradiol 17 beta - parenteral implant, device - oestradiol 17 beta steroid-estrogen active 43.9 mg/do - nutrition & metabolism - heifer (vealer) | heifer speyed (neutered young cow) | steer (castrated male cattle) | beef | bovine | bullock (young) | male ca - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

ELANCO AF0050 TYLAN 50 TYLOSIN PHOSPHATE PREMIX Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco af0050 tylan 50 tylosin phosphate premix

elanco australasia pty ltd - tylosin as the phosphate - oral powder, pre-mix - tylosin as the phosphate antibiotic active 50.0 g/kg - antibiotic & related - cattle - beef | pigs | poultry | poultry broilers (meat for human consum) | boar | bovine | breeders | broiler | bullocks | bull - antibiotic - anti-infective | ileitis | liver abscess | necrotic enteritis | promote animal growth | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed conversion | feed efficiency | finishing | fungal infections | girth galls | growth promotion | growth rate | infections | inflammed pads | itching | keratolytic | lacerations | liveweight gain | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds

ELANCO AH 0323 OESTRADIOL COMPUDOSE 200 Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco ah 0323 oestradiol compudose 200

elanco australasia pty ltd - oestradiol 17 beta - parenteral implant, device - oestradiol 17 beta steroid-estrogen active 25.7 mg/do - nutrition & metabolism - heifer (vealer) | heifer speyed (neutered young cow) | steer (castrated male cattle) | beef | bovine | bullock (young) | male ca - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

ELANCO AH0635 APRALAN SOLUBLE POWDER Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco ah0635 apralan soluble powder

elanco australasia pty ltd - apramycin - oral powder, pre-mix - apramycin antibiotic active 50.0 g - antibiotic & related - calf | pigs | poultry broilers (meat for human consum) | beef calf | boar | bovine | calf - poddy | calf - preweaning | calf - s - antibiotics - oral, parenteral | colibacillosis | enteritis associated with e.coli | salmonella spp. | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

ELANCO AF0472 PULMOTIL 200 TILMICOSIN PHOSPHATE PREMIX Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco af0472 pulmotil 200 tilmicosin phosphate premix

elanco australasia pty ltd - tilmicosin phosphate - oral powder, pre-mix - tilmicosin phosphate antibiotic active 200.0 g/kg - antibiotic & related - pigs | boar | gilt | piglet | sow | swine - pneumonia | bacterial pneumonia

ELANCO AF1304 ELANCOBAN G MONENSIN SODIUM PREMIX Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco af1304 elancoban g monensin sodium premix

elanco australasia pty ltd - monensin sodium - oral powder, pre-mix - monensin sodium antiprotozoal active 100.0 g/kg - nutrition & metabolism - cattle | cattle - feedlot | dairy cattle | goat | pasture cattle | poultry broilers (meat for human consum) | pullet-laying repl - bloat | coccidiosis | improve feed efficiency | improve reproductive performance | improvement of milk production | ketosis | productivity improvements | acetonaemia | bloated | colic | eimeria acervulina | eimeria brunetti | eimeria maxima | eimeria mivati | eimeria necatrix | eimeria tenella | elevated ketones | frothy bloat | gas colic | improving feed efficiency | increasing rate of weight gain | legume bloat | non-clinical ketosis | weight gain

Elaprase Unione Europea - inglese - EMA (European Medicines Agency)

elaprase

takeda pharmaceuticals international ag ireland branch - idursulfase - mucopolysaccharidosis ii - other alimentary tract and metabolism products, - elaprase is indicated for the long-term treatment of patients with hunter syndrome (mucopolysaccharidosis ii, mps ii). heterozygous females were not studied in the clinical trials.

Replagal Unione Europea - inglese - EMA (European Medicines Agency)

replagal

takeda pharmaceuticals international ag ireland branch - agalsidase alfa - fabry disease - other alimentary tract and metabolism products, - replagal is indicated for long-term enzyme-replacement therapy in patients with a confirmed diagnosis of fabry disease (α-galactosidase-a deficiency).

Vpriv Unione Europea - inglese - EMA (European Medicines Agency)

vpriv

takeda pharmaceuticals international ag ireland branch - velaglucerase alfa - gaucher disease - other alimentary tract and metabolism products, - vpriv is indicated for long-term enzyme-replacement therapy (ert) in patients with type-1 gaucher disease.

Revestive Unione Europea - inglese - EMA (European Medicines Agency)

revestive

takeda pharmaceuticals international ag ireland branch - teduglutide - malabsorption syndromes - other alimentary tract and metabolism products, - revestive is indicated for the treatment of patients aged 1 year and above with short bowel syndrome (sbs). patients should be stable following a period of intestinal adaptation after surgery.revestive is indicated for the treatment of patients aged 1 year and above with short bowel syndrome. patients should be stable following a period of intestinal adaptation after surgery.